Morphine-induced changes in histamine dynamics in mouse brain.
The effect of the acute morphine treatment on histamine (HA) pools in the brain and the spinal cord was examined in mice. Morphine (1-50 mg/kg, s.c.) administered alone caused no significant change in the steady-state levels of HA and its major metabolite, tele-methylhistamine (t-MH), in the brain. However, depending on the doses tested, morphine significantly enhanced the pargyline (65 mg/kg, i.p.)-induced accumulation of t-MH and this effect was antagonized by naloxone. A specific inhibitor of histidine decarboxylase, alpha-fluoromethylhistidine (alpha-FMH) (50 mg/kg, i.p.), decreased the brain HA level in consequence of the almost complete depletion of the HA pool with a rapid turnover. Morphine further decreased the brain HA level in alpha-FMH-pretreated mice. Morphine administered alone significantly reduced the HA level in the spinal cord, an area where the turnover of HA is very slow. These results suggest that the acute morphine treatment increases the turnover of neuronal HA via opioid receptors, and this opiate also releases HA from a slowly turning over pool(s).
D000818:Animals; D001921:Brain / Q000187:drug effects*; D001923:Brain Chemistry / Q000187:drug effects; D006632:Histamine / Q000032:analysis / Q000378:metabolism* / Q000494:pharmacology; D008297:Male; D008761:Methylhistamines / Q000032:analysis / Q000378:metabolism; D008762:Methylhistidines / Q000494:pharmacology; D051379:Mice; D009020:Morphine / Q000494:pharmacology*; D009270:Naloxone / Q000494:pharmacology; D010293:Pargyline / Q000494:pharmacology; D013116:Spinal Cord / Q000032:analysis / Q000187:drug effects
D008761:Methylhistamines; D008762:Methylhistidines; D009270:Naloxone; C028309:alpha-fluoromethylhistidine; D009020:Morphine; D006632:Histamine; D010293:Pargyline; C020404:tele-methylhistamine